Application

18105316 · METHODS OF TREATMENT OF DISEASES IN WHICH IL-13 ACTIVITY IS DETRIMENTAL USING ANTI-IL-13 ANTIBODIES

Filed 2023-02-03 · Granted · Patent 12129294 (2024-10-29) The official file ↗The patent and its PDF ↗ · Art unit 1649 · Examiner Christina M Borgeest Typical · CPC A61K 39/3955 · AbbVie Inc. · McCarter & English, LLP/Celgene & Abbvie

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

13.6 mo

to disposition 20.8 mo

Statutes raised

103 112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.